Melatonin differentially affects vascular blood flow in humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 2, 2011, Pages

  Cook, Jonathan S ^b   Sauder, Charity L ^a   Ray, Chester A ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cerebral; Conductance; Limb; Renal; Supplement

Indexed keywords

MELATONIN; PHENTOLAMINE; PLACEBO;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CIRCADIAN RHYTHM; CIRCULATION; CONDUCTANCE; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FOREARM BLOOD FLOW; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPATHETIC FUNCTION; VASCULARIZATION; VASOCONSTRICTION;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOREARM; HEART RATE; HUMANS; MALE; MELATONIN; PHENTOLAMINE; PLETHYSMOGRAPHY; REGIONAL BLOOD FLOW; RENAL CIRCULATION; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 79551472004     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00710.2010     Document Type: Article

References (24)

1. Aoki K, Stephens DP, Zhao K, Kosiba WA, Johnson JM. Modification of cutaneous vasodilator response to heat stress by daytime exogenous melatonin administration. Am J Physiol Regul Integr Comp Physiol 291: R619-R624, 2006.
2. Aoki K, Zhao K, Yamazaki F, Sone R, Alvarez GE, Kosiba WA, Johnson JM. Exogenous melatonin administration modifies cutaneous vasoconstrictor response to whole body skin cooling in humans. J Pineal Res 44: 141-148, 2008.
3. Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe A, Melis GB. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 83: 1417-1419, 1999. (Pubitemid 29205758)
4. Bliwise DL, Ansari FP. Insomnia associated with valerian and melatonin usage in the 2002 National Health Interview Survey. Sleep 30: 881-884, 2007.
5. Brzezinski A. Melatonin in humans. N Engl J Med 336: 186-195, 1997.
6. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB. Influences of melatonin administration on the circulation of women. Am J Physiol Regul Integr Comp Physiol 274: R335-R338, 1998.
7. Capsoni S, Stankov BM, Fraschini F. Reduction of regional cerebral blood flow by melatonin in young rats. Neuroreport 6: 1346-1348, 1995.
8. Doolen S, Krause DN, Dubocovich ML, Duckles SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345: 67-69, 1998. (Pubitemid 28179472)
9. 1 receptors in male rat caudal arteries. Eur J Pharmacol 439: 171-172, 2002.
10. Forsling ML, Wheeler MJ, Williams AJ. The effect of melatonin administration on pituitary hormone secretion in man. Clin Endocrinol (Oxf) 51: 637-642, 1999.
11. Geary GG, Krause DN, Duckles SP. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am J Physiol Heart Circ Physiol 273: H1530-H1536, 1997.
12. Masana MI, Doolen S, Ersahin C, Al-Ghoul WM, Duckles SP, Dubocovich ML, Krause DN. MT2 melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302: 1295-1302, 2002.
13. Morgan PJ, Barrett P, Howell HE, Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 24: 101-146, 1994. (Pubitemid 24061864)
14. Niijima A, Chun SJ, Shima T, Bizot-Espiard JG, Guardiola-Lemaitre B, Nagai K. Effect of intravenous administration of melatonin on the efferent activity of the adrenal nerve. J Auton Nerv Syst 71: 134-138, 1998.
15. Ray CA. Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans. J Physiol 551: 1043-1048, 2003.
16. Satake N, Oe H, Sawada T, Shibata S. The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmacol 22: 219-221, 1991.
17. Satake N, Oe H, Shibata S. Vasorelaxing action of melatonin in rat isolated aorta: possible endothelium dependent relaxation. Gen Pharmacol 22: 1127-1133, 1991.
18. Satake N, Shibata S, Takagi T. The inhibitory action of melatonin on the contractile response to 5-hydroxytryptamine in various isolated vascular smooth muscles. Gen Pharmacol 17: 553-558, 1986.
19. Shibata S, Satake N, Takagi T, Usui H. Vasorelaxing action of melatonin in rabbit basilar artery. Gen Pharmacol 20: 677-680, 1989. (Pubitemid 19232608)
20. Ting N, Thambyraja A, Sugden D, Scalbert E, Delagrange P, Wilson VG. Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 361: 327-333, 2000. (Pubitemid 30106346)
21. van der Helm-van Mil AH, van Someren EJ, van den Boom R, van Buchem MA, de Craen AJ, Blauw GJ. No influence of melatonin on cerebral blood flow in humans. J Clin Endocrinol Metab 88: 5989-5994, 2003. (Pubitemid 38033083)
22. Vandeputte C, Giummelly P, Atkinson J, Delagrange P, Scalbert E, Capdeville-Atkinson C. Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration. Am J Physiol Heart Circ Physiol 280: H420-H425, 2001.
23. Viswanathan M, Laitinen JT, Saavedra JM. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci USA 87: 6200-6203, 1990.
24. Weekley LB. Effects of melatonin on pulmonary and coronary vessels are exerted through perivascular nerves. Clin Auton Res 3: 45-47, 1993.